NetworkNewsBreaks – Green Hygienics Holdings Inc
Post# of 214
(Total Views: 586)
Posted On: 08/19/2021 4:14:41 PM
NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names Former J&J Director as New Chief Scientific Officer
Green Hygienics (OTCQB: GRYN), an innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, has announced that Dr. Francesca Serraino Fiory will serve as the company’s new chief scientific officer. In her new role, Fiory will manage product development, including GRYN’s multibrand portfolio, and oversee research and development efforts under TruLife Biotech, the company’s wholly owned subsidiary. In addition, she will head up partnerships with both academic institutions and research centers and will navigate the company across the global regulatory landscape. Fiory has worked for several major players in the pharmaceutical industry including Pfizer, where she started in regulatory and medical affairs; Johnson and Johnson (“J&J”), where she was head of regulatory and medical affairs at Johnson & Johnson Consumer Health Care, Italy; and Perrigo Pharma, where she was director of regulatory, quality and medical affairs and also supervised the Italian affiliate’s portfolio, which included medicinal products, cosmetic products, medical devices, food supplements, biocides and veterinary products. A certified nutritional consultant, clinical master herbalist and aromatherapist, and a certified holistic health practitioner in traditional Chinese medicine, Fiory brings with her 20-plus years of expertise and an impressive knowledge of the pharmaceutical environment, medicinal products, herbals, medical devices, cosmetics and food supplements.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Green Hygienics (OTCQB: GRYN), an innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, has announced that Dr. Francesca Serraino Fiory will serve as the company’s new chief scientific officer. In her new role, Fiory will manage product development, including GRYN’s multibrand portfolio, and oversee research and development efforts under TruLife Biotech, the company’s wholly owned subsidiary. In addition, she will head up partnerships with both academic institutions and research centers and will navigate the company across the global regulatory landscape. Fiory has worked for several major players in the pharmaceutical industry including Pfizer, where she started in regulatory and medical affairs; Johnson and Johnson (“J&J”), where she was head of regulatory and medical affairs at Johnson & Johnson Consumer Health Care, Italy; and Perrigo Pharma, where she was director of regulatory, quality and medical affairs and also supervised the Italian affiliate’s portfolio, which included medicinal products, cosmetic products, medical devices, food supplements, biocides and veterinary products. A certified nutritional consultant, clinical master herbalist and aromatherapist, and a certified holistic health practitioner in traditional Chinese medicine, Fiory brings with her 20-plus years of expertise and an impressive knowledge of the pharmaceutical environment, medicinal products, herbals, medical devices, cosmetics and food supplements.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)